InvestmentJul 29, 2026, 09:12 AM
HCW Biologics Prices $1.6M Private Placement Offering
AI Summary
HCW Biologics Inc. announced the pricing of a $1.6 million private placement offering with a group of investors, including company officers and directors. The offering involves 618,682 units, each comprising common stock (or pre-funded warrants) and the right to receive common stock purchase warrants, pending stockholder approval. The net proceeds will fund clinical trials for HCW9302, advance IND-enabling studies for HCW11-018b and HCW11-040, and support general corporate purposes.
Key Highlights
- Priced $1.6 million private placement offering.
- Issued 618,682 units, each consisting of common stock/pre-funded warrant and a common warrant right.
- Each unit priced at $2.585 (common stock) or $2.5849 (pre-funded warrant).
- Initial issuance includes 218,682 shares of Common Stock and 400,000 Pre-Funded Warrants.
- Common Warrants to purchase up to 618,682 shares require stockholder approval.
- Proceeds will fund clinical trials for HCW9302 and advance IND-enabling studies.
- Company officers and directors participated in the offering.
Price Impact
More from HCWB